Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

NCT01012570 is registered in ClinicalTrials.gov with Gerhard Rogler as lead sponsor.

NCT NCT01012570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01012570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients
Lead sponsor
Gerhard Rogler
Phase
Observational
Overall status
Terminated
Start date
August 31, 2009
Completion date
Not reported
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease